Presbyopia Correction: Can We Match Mother Nature?

ACADEMY 2014 DENVER
Times
Friday Edition
Your AAO
News Source
Friday
•This year’s Primary Care
Symposium briefed attendees on
the latest treatment protocols for
posterior segment disease .­...... 3
•This morning, Ezell Fellows
Present: A Sampler of Current
Low Vision Research.............. 4
Presbyopia Correction:
Can We Match Mother Nature?
P
resbyopia is (or will be)
everyone’s problem.
To illustrate this, Paul
Kaufman, MD, addressed the
youngest optometrist in the
packed ballroom: “As young as
you think you are, you already
have this disease.” At yesterday’s Monroe J. Hirsch Symposium, Dr. Kaufman and two
other speakers presented their
research to this presbyopic and
pre-presbyopic audience.
Imaging of Accommodation
•Want to learn more about
the Student Fellowship
program?....................................5
•This year’s list of ‘Academy
Award’ winners include several
A-listers................................8,9
• List of Exhibitors...................10
Susana Marcos, PhD, professor of research at the Instituto
de Óptica, in Madrid, Spain,
talked about new imaging technologies to measure the optical
and structural properties of the
crystalline lens during accommodation and in presbyopia.
Using 3D OCT, “we can assess
the fluctuations of accommodation looking directly at the
crystalline lens,” she said.
Both lens geometry and another age-related property of the
Credit: VioBio Lab
•Join the Academy in recognizing
its new Fellows and Diplomates
tomorrow night at 7:00 PM......4
•Scientific discoveries and recent
product updates presented at
the AAO Press Conference....13
3D OCT biometry can be used to quantify accommodation, as shown by Susana Marcos, PhD.
lens, the gradient index, contribute to the change of optical
aberrations, Dr. Marcos said.
The idea is to use the findings
from these imaging technologies
to quantify the performance of
the latest accommodative IOL
designs and, better yet, to design
new multifocal lens designs for
presbyopic correction.
Eye to Eye with
Mother Nature?
Research in presbyopia has
largely focused on the crystalline
lens—but “the lens is not the
only game in town,” said Dr.
Kaufman, professor and chair
of ophthalmology and visual
sciences at the University of
Wisconsin-Madison.
Classical teaching holds that
presbyopia is caused by age-related loss of lenticular elasticity.
“But, there’s also a concurrent
decline in movement of the ciliary processes,” he said.
Interestingly, Dr. Kaufman
described an ocular structure
called the vitreous zonule that
appears to play a role. It acts
like a pulley to move the ciliary muscle during accommodation. But, stiffening of this
vitreous zonule as we age may
diminish accommodation. So,
“when you cut it in a presbyopic
eye [in monkey experiments],
much of the movement of the
ciliary muscle is restored,” Dr.
Kaufman said.
This, he indicated, would
explain, to some extent, why
full accommodation can’t be restored by accommodating intraocular lenses. “You wonder why
Accommodating IOLs aren’t nearly as good as
the lens Mother Nature designed, said
Paul Kaufman, MD.
you don’t get more than 2D out
of an accommodating IOL? The
answer is that [accommodating
intraocular] lenses aren’t nearly
as good as what Mother Nature
designed [with the crystalline
lens],” he said.
Someday, a biochemical or genetic treatment might be found
to alter the connective tissue,
Dr. Kaufman said, but those
developments are quite far off.
Better Than Bifocals?
Stephen D. McLeod, MD,
professor and chair of the
ophthalmology department at
the University of California San
Francisco, wrapped up the symposium with an analysis of the
advantages and limitations of
corneal, intrastromal and intraocular lens options for presbyopia. “There are many different
ways to try to skin this cat,”
he said. “We still have a lot of
challenges ahead [with advanced
IOLs], but hopefully in a few
years, we’ll be doing better than
bifocals and progressives.”
AAO TIMES NOVEMBER 14, 2014
1
ACADEMY 2014 DENVER
REVIEW OF OPTOMETRY
WWW.REVIEWOFOPTOMETRY.COM
Primary Care Goes Posterior
A
t yesterday morning’s
Primary Care Section
Symposium, “Primary
Care of the Posterior Segment,”
an all-star panel of lecturers provided attendees with a rapid-fire
update on an array of retinal and
macular disease topics.
Don’t Pass Over New
Plaquenil Protocols
Following an introduction from
symposium moderator Christopher Lievens, OD, MS, FAAO,
Blair Lonsberry, OD, MS, FAAO,
reviewed current screening guidelines for hydroxychloroquineinduced retinal toxicity.
In 2002, the American Academy of Ophthalmology (AAO)
established ocular examination
guidelines for screening patients
on Plaquenil (hydroxychloroquine, Sanofi-Aventis) therapy,
Dr. Lonsberry said. Testing
included a comprehensive eye
exam that consisted of an assessment of the posterior segment
with careful evaluation of associated macular changes or signs of
retinal disease. An Amsler grid
or central 10-2 visual field test
was recommended, and baseline
fundus photography was considered optional.
But, following the advent of
more sensitive objective testing
capabilities—including multifocal electroretinogram, spectraldomain optical coherence
tomography and fundus autofluorescence—the AAO revised its
screening guidelines in 2011. “It
is now recommended that, along
with 10-2 automated fields,
at least one of these advanced
procedures be used for routine
screening, where available,” Dr.
Lonsberry said.
Macular Edema Tx Update
Next, Megan Hunter, OD,
FAAO, discussed how treatments for macular edema
secondary to central retinal vein
occlusion (CRVO) have improved during the last decade.
“Throughout the 1980s and
1990s, macular edema associated with vein occlusion was
largely untreatable,” she said.
Following publication of the
Central Retinal Vein Occlusion
Study, researchers learned that
grid laser photocoagulation effectively reduced macular edema
but didn’t yield an improvement in visual acuity. “Thus,
observation became the only
treatment option,” added Dr.
Hunter.
Then, in the early 2000s, retinal specialists began administering intravitreal corticosteroid
injections to CRVO patients
with significant macular edema.
“This treatment approach
reduced edema through antiinflammatory and antiproliferative effects,” Dr. Hunter said.
“However, intravitreal steroid
use carries the potential for
significant side effects, including
elevated intraocular pressure
and an increased incidence of
cataract formation.”
Today, however, the most
effective treatment option for
macular edema secondary to
CRVO seems to be intravitreal anti-vascular endothelial
growth factor (anti-VEGF) therapy. “Anti-VEGF drugs, such as
bevacizumab, ranibizumab and
aflibercept, treat both neovascularization and macular edema
effectively, and help increase
patients’ best-corrected visual
acuity,” Dr. Hunter said. The
latest anti-VEGF agent, Eylea
(aflibercept, Regeneron), has
been shown to have a longer
half-life in the eye than both
bevacizumab and ranibizumab.
“The retinal specialist I work
with typically administers Eylea
to macular edema patients once
a month for three months, then
once every six to eight weeks
thereafter,” she said.
Dialed-in on Diabetic
Retinopathy
Then, Mohammad Rafieetary,
OD, FAAO, discussed how
primary care optometrists can
become more involved in the
detection and management of
diabetic eye disease.
More Americans experience
vision loss secondary to diabetic
retinopathy and diabetic macular edema than to glaucoma,
he said. “Interestingly, optometrists are able to treat glaucoma At yesterday’s Primary Care Symposium,
directly with topical medicaDr. Rafieetary discussed how optometrists can
tions––but unfortunately cannot become more involved in the management of
patients with diabetic eye disease.
do the same for diabetic eye
disease. So, the best services we
can provide to our patients are
standard treatment, the adeducation about the underlying
dition of anti-VEGF therapy
condition and early monitoring
reduces neovascularization
via fundus photography and
and helps restore lost vision in
spectral-domain optical coherdiabetes patients, Dr. Rafieetary
ence tomography.”
said. “The only significant risk
Once diabetic retinopathy is
associated with anti-VEGF
detected, primary care optomtherapy in this capacity is an
etrists are well positioned to
elevated potential for tractional
refer the patient to a specialist
retinal detachment. But, regular
for appropriate treatment. “[In
monitoring with SD-OCT can
our clinic] we don’t often refer
easily detect this,” he added.
diabetes patients for
Residents Day at Academy
intravitreal steroidal
2014 Denver
injections, because
that approach is
Saturday, November 15, 2014
not curative,” Dr.
Sponsored by
Rafieetary said.
“Instead, we prefer
sending patients out
for combination
Residents Day is a forum where residents have the
anti-VEGF therapy
opportunity to present their interesting grand rounds case
and panretinal phoreports! Papers will be presented from 8:00 PM – Noon
tocoagulation.”
in Room 708/710/712 and posters will be presented
While panretinal
from 1:30 PM to 3:30 PM in the Four Seasons
photocoagulation
Ballroom.
remains the gold
AAO TIMES NOVEMBER 14, 2014
3
ACADEMY 2014 DENVER
REVIEW OF OPTOMETRY
WWW.REVIEWOFOPTOMETRY.COM
EZELL FELLOWS PRESENT:
A Sample of Current Low Vision Research
Today, 10:00 AM – 12:00 PM, Rooms 401-403
O
ffered by the American Optometric
Foundation since 1947, the Ezell
Fellowship program supports optometric research and education with the
goal of improving clinical patient care. This
year, three eminent researchers will review
a variety of topics centered upon low vision
rehabilitation.
• Robert W. Massof, PhD, FAAO, professor of ophthalmology and neuroscience at the
Johns Hopkins University School of Medicine, will begin the presentation with an overview of the relationship between low vision
disorders and specific contributing factors,
such as patient age, environmental variables
and coexistence of other chronic diseases.
Such individualized considerations inherently
help us more effectively tailor patients’ comprehensive care plans, notes Dr. Massof.
The lecture also will explore different
methods of determining intervention efficacy—including performance measures like
timed Instrumental Activities of Daily Living
(IADL) testing; use of clinical techniques like
the Functional Independence Measure (FIM)
and Goal Attainment Scaling (GAS); and
methods for determining intervention effec-
tiveness like Visual Functioning Questionnaires (VFQ).
• Next, Susana Chung, OD, PhD, FAAO,
professor of optometry and vision science at
the University of California, Berkeley, will
discuss recent research on improving visual
function via perceptual learning in patients
with central vision loss.
“Evidence suggests that the adult visual
system retains [a] certain degree of plasticity
and can be altered by experiences in life,” Dr.
Chung says. “Recently, we observed evidence
suggesting that the visual system of people
with longstanding macular lesions is also
capable of modifying its responses to visual
stimuli based on experiences, even when the
vision loss occurs late in life.”
Dr. Chung’s lecture will cover the concept
of the preferred retinal locus (PRL), a retinal
region unaffected by lesions that is adopted
by age-related macular degeneration (AMD)
patients as their “new fovea.” Additionally,
she’ll describe oculomotor re-referencing as
an indicator of visual system plasticity despite
macular lesions; psychophysical evidence
for a shift in the reference location; and
the clinical implications of the plasticity in
Annual Fellowship Banquet
Saturday, November 15 –
7:00 PM to 10:00 PM
(Black Tie Optional)
J
oin us in recognizing the new Fellows and Diplomates! Enjoy the
camaraderie as we celebrate those reaching this milestone in their
careers and toast the ending of another great Academy meeting.
Use your banquet ticket, which was printed with your badge at
registration, to get into the event. Seating is first come, first served.
Please note! If you do not plan on attending the banquet, please
stop by the Academy’s booth in the Exhibit Hall (#437) to donate
your ticket to a student attendee.
4
AAO TIMES NOVEMBER 14, 2014
a visual system affected by vision loss. Dr.
Chung also will review a clinical case that illustrates the performance of an AMD patient
both during and after a perceptual learning
program.
• Then, Bradley Dougherty, OD, PhD,
FAAO, assistant professor of vision science at
the Ohio State University College of Optometry, will close the seminar with an exploration of factors that may affect road safety in
bioptic drivers. Bioptic systems supplement
the patient’s natural vision with a small
telescopic system to improve the sharpness
of their far vision, allowing them to more
clearly see street signs, traffic signals and
other distant objects ahead, he suggests.
Additionally, Dr. Dougherty will describe
the history of bioptic driving, including how
telescopic spectacles are designed and used,
their role in current driving licensure and
related controversies. He’ll then review research outlining the rate of motor vehicle collisions involving bioptic drivers vs. non-bioptic drivers; the effectiveness of bioptic testing
and training; and the effect of different visual
and demographic factors on bioptic drivers
compared to non-bioptic drivers.
Academy Education Online
The Academy’s Live Learning Center connects you to educational session
recordings from American Academy of Optometry annual meetings. Recordings
from Academy 2014 Denver will posted online after the meeting, and learners
can already access previous Academy meeting recording packages!
• If you missed a particular presentation or couldn’t make it to the conference
this year, here’s your chance to catch up on the sessions you were unable to
experience live. Recorded sessions make great training tools between conferences and will enrich your professional development year-round.
• As a thank-you to our valued members, we’re excited to offer complimentary session recordings for our members from the 2014 meeting, as well as the
previous five meetings.
• Additionally, tests are available for purchase online for just $25. Start claiming COPE-approved distance learning credits today!
• Visit the Academy’s Live Learning Center at http://aaopt.sclivelearningcenter.com. If you encounter any technical issues or need your account login,
please contact the support help line at 289-695-5400 (Monday through Friday,
9:00 AM - 5:00 PM eastern time), or send an email to multiviewMediaSupport@
multiview.com.
ACADEMY 2014 DENVER
REVIEW OF OPTOMETRY
WWW.REVIEWOFOPTOMETRY.COM
What Exactly is Student Fellowship?
Y
ou may have noticed the plethora of
students attending lectures, sitting in
on workshops, lingering in paper and
poster sessions, and packing into the Academy Business Meeting. You may have even
felt exhilarated by their passion for Academy
education! While they very well could be trying to cram as much optometry knowledge
into their brains as possible, it’s more likely
that they’re participating in the Student Fellowship program.
So, what exactly is Student Fellowship?
The Student Fellowship program was created
to encourage students to experience the entire
meeting, hoping that it would stimulate
improved integration of all the opportunities
offered at the meeting and encourage future
involvement in the Academy.
To participate, students must attend a
mandatory orientation breakfast followed
by a certain number of CE hours, paper and
poster sessions, special sessions, the Academy business meeting and a Section or SIG
symposium. All students who complete the
EyeMAP™
TODAY’S HIGHLIGHTS
Scientific Program For Friday, November 14
What’s happening with the Scientific Program this year? The Scientific
Program Committee has revamped the program this year to offer attendees
different options in paper and poster sessions.
Here are a few highlights:
Today’s paper sessions:
•Does Trans-synaptic Degeneration Exist? (Rooms 201-203, 10:30 - 11:30 AM)
•Anterior Segment/Contact Lens 4 (Rooms 205-207, 10:00 AM - Noon)
•Health Policy and Delivery (Rooms 201-203, 2:00 - 3:30 PM)
•RGP Contact Lenses (Rooms 205-207, 2:00 - 3:00 PM)
Today’s poster sessions:
Posters will be displayed from 9:00 AM to 4:00 PM in the Four Seasons
Ballroom. Odd-numbered authors will be present from 10:00 AM - Noon and
even-numbered authors will be present from 2:00 - 4:00 PM.
Topics include:
•Cornea/Anterior Segment/Contact Lens
•Glaucoma
•Health Policy
•Neuro-Ophthalmic/Orbit
•Optometric Education
•Posterior Segment
•Systemic Disease
Tomorrow’s paper sessions:
•Anterior Segment/Contact Lens 5 (Rooms 201-203, 8:30 AM - Noon)
•Low Vision (Rooms 201-203, 2:30 - 4:30 PM)
Interested in presenting a paper or poster at Academy 2015 New Orleans?
The Scientific Program abstract submission window will be open from May 1
through May 31, 2015. More information is available online at www.aaopt.org.
6
AAO TIMES NOVEMBER 14, 2014
requirements receive a Student Fellow certificate, an Academy lapel pin and complimentary student registration for Academy 2015
New Orleans.
To date, over 700 optometry students have
become Student Fellows. This year, nearly
500 enthusiastic students will participate.
So, as you see students hurriedly walking
through the halls of the convention center,
kindly point them in the direction of the
nearest contact lens session or scientific talk.
They are likely to appreciate it greatly!
(Meeting Activities Planner)
W
ith all the papers,
posters, lectures,
workshops,
symposia and social events
happening at Academy
2014 Denver, even the
most organized can get a
little overwhelmed! That’s
why the Academy provides
EyeMAP™ (Meeting Activities Planner), a program designed to help you
create and manage your
personal schedule during
the meeting.
Use EyeMAP™ to:
•Browse and search all available lectures, workshops, papers and posters, and special events.
•Add sessions and personal appointments to your schedule.
•Access session handouts before and during the meeting.
•Complete session evaluations.
•Find information about the city of Denver.
•Locate exhibitors in the Exhibit Hall.
EyeMAP™ can be accessed online at http://aao-eyemap.
org on your computer, smartphone or tablet, with no app
download required. Please log in using the same username
and password combination you used to register for the
meeting.
ACADEMY 2014 DENVER
REVIEW OF OPTOMETRY
WWW.REVIEWOFOPTOMETRY.COM
The Academy Presents: 2014 Awards
D
on’t miss the 2014
Awards Ceremony,
during which we will celebrate those who have demonstrated their contributions to the
advancement of optometry and
vision science. The 2014 award
recipients will be recognized
on Friday, November 14 from
8:00 to 10:00 AM in the Four
Seasons Ballroom of the Colorado Convention Center. Join us
to hear the Charles F. Prentice
Lecture and the Glenn A. Fry
Lecture (one hour of CE provided), and to recognize and honor
these outstanding individuals.
Charles F. Prentice Medal
and Lecture
The Charles F. Prentice Medal
is the Academy’s top award and
lecture at the annual meeting,
and is presented to an individual
who has made a significant contribution to the advancement of
knowledge through research in
the visual sciences.
Brien A.
Holden, PhD,
DSc, FAAO, has
made substantial
contributions to
our understanding of the mechanisms underlying
the development
and treatment of myopia, the
evaluation of uncorrected refractive error, and the relationship
between corneal physiology,
contact lenses and the metabolic
and physiological factors that
are required for maintaining
the integrity of the cornea. In
addition, Dr. Holden has been
able to develop a unique model
for optometric research, collaborate with many colleagues
worldwide, acquire considerable
research funding, and develop
methods and procedures that
are utilized by many investigators and clinicians throughout
the world.
8
AAO TIMES NOVEMBER 14, 2014
The Glenn A. Fry Award
and Lecture
The Glenn A. Fry Award and
Lecture is sponsored by the
American Optometric Foundation and recognizes a distinguished scientist or clinician
for his or her current research
contributions.
Lyndon W.
Jones’, PhD,
FCOptom,
FAAO, research
is related to
contact lenses
and dry eye,
meibomian gland
function, and tear
film characteristics.
He has been actively involved
in the ongoing issues concerning
the ocular response to contact
lens solutions. Dr. Jones has
received significant research
funding and has published more
than 160 publications in peerreviewed journals.
In addition, Dr. Jones is an
outstanding instructor and superb clinician. Dr. Jones was in
private practice in optometry for
12 years prior to assuming an
academic position at an optometry school, and he has participated in several significant
leadership positions throughout
the years.
Irvin M. and Beatrice Borish
Award
The Borish Award recognizes
an outstanding young researcher
who has shown exceptional
promise to conduct independent
optometric research directly
related to etiology, prevention,
detection, diagnosis or management of clinical
eye disorders.
Laura E.
Downie, BOptom, PhD
(Melb), FAAO,
is a highly skilled
clinician with
expertise in anterior eye disease
and contact lenses. She has also
produced exceptional research
related to vascular, neural and
glial cell changes in the retina
and their interactions, and was
instrumental in demonstrating
the neuro-protective potential of
Valsartan, a renin-angiotensin
modulator.
AAO-Essilor Award for
Outstanding International
Contributions to Optometry
The International Award recognizes an individual(s) or organization whose direct efforts
and contributions have resulted
in unquestionable significant
and extraordinary advances in
optometry and eye care internationally.
Ms. Tone
Garaas-Maurdalen is a Norwegian optometrist
who has elevated
optometry into
a primary health
care profession
in Europe and
has also extended these efforts
to countries such as Iceland,
Sweden and Switzerland.
Additionally, she has been a
tireless participant on the Legislation, Registration and Standards Committee of the World
Council of Optometry (WCO),
and has been the President of
the WCO since 2011. Her contributions have had a significant
positive impact on the expansion of optometry throughout
Europe.
Carel C. Koch
Memorial Medal
The Carel C. Koch Memorial
Medal is awarded to a person
who has made outstanding contributions to the enhancement
and development of relationships between optometry and
other professions.
Serge Resnikoff,
MD, PhD, has
spent the majority of his career
promoting public
health initiatives worldwide
through the
World Health Organization
(WHO). With his dedication,
the World Council of Optometry became officially recognized
as an organization within the
WHO. This has strengthened
the international collaboration
between optometry and ophthalmology, as well as other
health care groups. His efforts
have greatly expanded and
extended the role of optometry
in providing low-cost eye care
to individuals throughout the
world.
Vincent Ellerbrock Clinician
Educator Award
The Vincent Ellerbrock Clinician Educator Award is presented to a distinguished clinician
who has made outstanding and
sustained contributions to the
Academy’s Lectures and Workshops program.
The 2014
Ellerbrock
Award recognizes two
outstanding
individuals, Drs.
Ron Melton and
Randall Thomas,
for their achievements related
to more than
20 years of
participation
in the Lectures
and Workshop
program. Both individuals are
exceptional speakers who annually utilize their clinical experience and expertise to provide
salient suggestions to clinicians
related to the diagnosis and
ACADEMY 2014 DENVER
REVIEW OF OPTOMETRY
management of ocular disease,
inflammation, infection, trauma
and a variety of other common
topics that occur in clinical
practice.
Life Fellowship Award
The distinction of Life Fellowship was created to provide
recognition to those Fellows
who, through long-time membership in the Academy, have
rendered distinguished service
to the science and art of optometry.
Satya Verma,
OD, FAAO,
has held many
leadership roles
in optometry and
has been the Cochair and Chair
of the National
Academy of Practice in Optometry.
He is the President-elect of the
National Academies of Practice,
and has been a long-standing
member of the National Council
on Aging. In these and other
roles, Dr. Verma has served as
a spokesperson and leader for
optometry and has dramatically
improved the public awareness of the benefits and service
that optometry has to offer the
general public. His contributions and dedication have had
a marked positive effect on the
profession.
WWW.REVIEWOFOPTOMETRY.COM
Max Schapero Memorial Lecture Award
The Schapero Award, which is the Section on Cornea, Contact Lenses &
Refractive Technologies’ highest award, honors a clinician, researcher, or
scholar who has made a significant contribution to the cornea and contact
lens field by virtue of his/her publications, lectures or research efforts.
This year’s honoree is Michel Guillon, PhD, FCOptom, FAAO, an educator
and PhD candidate mentor and researcher at Aston University. For more
than 25 years Dr. Guillon has been Director of the Ocular Technology Group, performing high
level research focusing on contact lenses and dry eye.
Michael G. Harris Award for
Excellence in Optometric Education
Presented by the American
Optometric Foundation, the
Harris Award recognizes an
optometric educator who has
demonstrated ongoing and
consistent excellence in education of optometry students and/
or advancement of optometric
education.
Edward J.
Revelli, OD,
FAAO, is a
tireless instructor and teacher
who has been
dedicated to
providing the
best instruction and training to
optometry students over many
years, and constantly upgrades
and improves the optometric
curriculum. Additionally, he has
been able to enhance the clinical
skills and expertise of faculty
in new and expanding areas of
Garland W. Clay Award
The Garland Clay Award is presented to the authors of the manuscript published in Optometry &
Vision Science that has been most widely cited in the world research literature in the preceding
five years and has the vote of the Optometry & Vision Science Editorial Board.
The 2014 Clay Award paper is: “Biomechanics of the Sclera in Myopia: Extracellular
and Cellular Factors,” and its authors are Neville A. McBrien, MCOptom, PhD, Andrew I.
Jobling, PhD, and Alex Gentle, PhD, FAAO. The article was published in the January 2009
issue of Optometry & Vision Science.
optometry. His methods are
highly effective and he is wellliked and greatly respected by
students and his peers.
Section on Cornea, Contact
Lenses & Refractive
Technologies Awards
These awards will be presented at the Section Awards
Ceremony and Max Schapero
Lecture, Friday, November 14,
5:00 - 6:00 PM, in Rooms 601607 of the Colorado Convention Center.
Founders’ Award
The Founders’ Award is presented to the individual, group,
or company who has made an
outstanding contribution to the
clinical aspect to the art or science of contact lens fitting.
This year’s
awardee is JeanLouis Blanchard,
OD, an optometrist, clinician,
researcher, and
educator. Dr.
Blanchard founded Blanchard
Laboratories, which developed
modern gas permeable, aspheric,
multifocal technology.
Exemplary Service Award
The Exemplary Service Award
honors those who have rendered
extraordinary
and/or distinguished contributions to the Section on Cornea,
Contact Lenses
and Refractive
Technologies.
This year’s awardee is David
Rosenbloom, OD, FAAO (posthumously). Dr. Rosenbloom
was an avid supporter of the
profession as well as the Lion’s
Clubs’ mission. A beloved colleague with an ever- present
smile, he will continue to be
missed.
Public Health &
Environmental Vision Section
Award
This award and lecture will be
presented at the Public Health
& Environmental Vision Section Symposium on Wednesday,
November 12, 4:00 - 5:00 PM,
in Rooms 405-407 of the Colorado Convention Center.
Henry B. Peters Memorial
Award in Public Health and
Environmental Vision
The Henry B. Peters Memorial
Award recognizes an individual
for his/her exemplary contributions to public health and/or
environmental vision over many
years.
This year’s
inaugural awardee is Alden N.
Haffner, OD,
PhD, FAAO. Dr.
Haffner is an
eminent educator
and passionate
advocate for public health optometry. He was the founding
President of the State University
of New York College of Optometry, and is credited with
organizing the historic LaGuardia Conference in 1968 that
launched optometry’s transition
from vision care to eye care
and the profession’s drive for
pharmaceutical prescriptive
authority and primary eye care
recognition.
We look forward to seeing you
at these Awards Ceremonies
to honor these distinguished
individuals, acknowledging the
countless contributions they
have made in advancing our
profession.
AAO TIMES NOVEMBER 14, 2014
9
ACADEMY 2014 DENVER
REVIEW OF OPTOMETRY
WWW.REVIEWOFOPTOMETRY.COM
AAO Exhibits
T
he Academy Exhibit Hall is the perfect place to experience cutting edge
products and services. Remember, badges are required for admission into the
Exhibit Hall. Hall hours are as follows:
Friday, November 14, 2014
Company Name
Booth Number Company Name
ABB Optical Group
907
Abbott Medical Optics
903
AccuLens Inc.
1029
Acuity Pro/VisionScience Software, Inc 528
Advanced Ocular Care
311
Advanced Vision Technologies (AVT) 1108
Adventure in Colors, Inc
945
Akorn Pharmaceuticals
1002
Alcon418
Alden Optical
517
All About Vision
1122
Allergan721
American Academy of Optometry
437
American Board of Certification in
Medical Optometry
1116
American Board of Optometry
545
American Optometric Foundation
737
Annidis Health Systems
1105
Art Optical Contact Lens Inc.
622
ARVO745
Bausch + Lomb
503
BIOD, LLC
747
Biosyntrx304
BioTissue403
Blanchard Contact Lens, Inc.
831
Blue View Vision
933
Brien Holden Vision Institute
529
Bruder Healthcare Company
911
Canon USA
306
CareCredit413
Carl Zeiss Meditec, Inc.
511
Carl Zeiss Vision, Inc
610
Chadwick Optical
334
Chemistrie Eyewear
919
Colorado Optometric Association
307
Compulink530
CooperVision, Inc.
729
Designs for Vision
333
DGH Technology, Inc.
829
Diagnosys LLC
341
Diopsys LLC
909
Elsevier, Inc.
1103
Enhanced Vision
329
Enovative Technologies
1114
Envision University
328
Eschenbach Optik of America
728
Essilor of America
308
Eye Designs
508
Eye Photo Systems, Inc.
442
Eyefinity611
EyeMed Vision Care
432
Fashion Optical Displays
941
10
11:00 AM – 3:00 PM
AAO TIMES NOVEMBER 14, 2014
Booth Number
Fellows Doing Research SIG
445
First Vision Media Group, Inc.
519
FOXFIRE Systems Group
914
Frame Displays
309
Freedom Scientific Inc.
335
Freedom Meditec
644
Good Lite
813
Haag-Streit/Reliance USA
629
HAI Laboratories, Inc.
615
HealthCare Professional Funding
Corporation506
Heidelberg Engineering
708
Heine415
Hoya Vision Care
320
HumanWare330
Icare-USA916
iMatrix340
Infinite Therapeutics
930
Infinite Trading
305
Innova Systems
314
Johnson & Johnson Vision Care, Inc.
703
Keeler Instruments
912
King-Devick Test
1031
KMK Educational Services LLC
1018
Konan Medical USA
523
Leiter’s Compounding
302
Lippincott Williams & Wilkins,
Wolters Kluwer Health
1117
Lombart Instrument
429
Lounge637
LS&S Products Inc.
331
M&S Technologies
620
Maculogix, Inc.
428
Marco1008
Marshall B. Ketchum University
943
Menicon704
Metro Optics
915
Modern Design Architects
407
MODO Eyewear
303
National Eye Institute
744
National Keratoconus Foundation
1110
National Vision Inc.
502
NBEO-Board Certification Inc.
342
NCI Vision Systems
1032
NEOD, Inc.
1040
Nicox, Inc.
815
Nidek409
NOVA Southeastern University
844
NovaBay Pharmaceuticals Inc.
1121
OASYS®803
Ocular Melanoma Foundation
645
Note to those interested in booth
space for Academy 2015 New Orleans:
Stop by the Exhibit Manager’s office located
near Exhibitor Services and ask for Betty
Taylor. She will be happy to help you select a
prime booth location and get you registered for
2015.
Company Name
Booth Number
Ocular Nutrition Society
510
Oculus, Inc.
616
Ocusci Inc.
944
Ocusoft, Inc.
1033
Ocutech Inc.
332
Optelec434
Optometry Times
343
Optos621
Optovue1020
Pain Point Medical Systems Inc
1109
PentaVision LLC
1009
Practice Director
1021
Precision Vision
1034
Presenta Nova Inc.
935
Primary Care Optometry News and
Healio.com By SLACK Incorporated
1016
PRN Physician Recommended
Nutriceuticals647
Reichert, Inc.
713
RETILAB746
Review of Optometry
404
Rysurg, LLC
512
Sensor Medical Technology
917
Shire402
Smart Vision Labs
646
Solutionreach931
Sonomed Escalon
1037
Stereo Optical
521
Synergeyes814
TearLab, Corp.
408
TearScience921
Topcon Medical Systems, Inc.
821
Tru-Form Optics
928
U.S. Jaclean, Inc.
547
Unilens Corporation
1015
US Ophthalmic
1004
Valley Contax, Inc.
1111
Veatch Ophthalmic Instruments
1120
Visionary Optics LLC
1010
Vmax Vision Inc
1028
VOLK Optical
929
VOSH International
411
VRMagic440
VSP Global
609
VSP Global/Vision Care
603
VSP Optics Group
607
Walmart Stores, Inc. / Sam’s Club
316
Wells Fargo Practice Finance
812
Williams Group
1021
World Council of Optometry
845
X-Cel Contacts
1003
Zeavision446
ACADEMY 2014 DENVER
REVIEW OF OPTOMETRY
WWW.REVIEWOFOPTOMETRY.COM
Monroe J. Hirsch Memorial Research Symposium
Adaptive Optics: The Next Ophthalmic Imaging Frontier?
Thursday
8:00 AM –10:00 AM
Hall 4E
Clinical Application of AO
Austin Roorda, PhD, Professor of Vision
Science and Optometry at University of
California–Berkeley School of Optometry,
will discuss “Translating Advanced Retinal
Imaging into Clinical Application.”
“Over the past two decades, we have
witnessed major advances in technologies for
ophthalmic imaging and vision testing,” Dr.
Roorda says. “The implementation of AO
and eye tracking into scanning laser ophthalmoscopes and OCT systems are driving
a paradigm shift in how retinal imaging is
being used to study eye disease.”
For example, the counting of cone photoreceptor cells—a technique that has traditionally required specialized laboratory
microscopes—is now being done
with an AO ophthalmoscope in
a clinical trial to measure disease
progression.
Dr. Roorda’s talk will discuss
the challenges and opportunities
in translating these technologies
for clinical application.
Will you be using AO in your
practice any time soon? “Tracking OCT with micro-vascular
imaging will be common” in the
average practice, he predicts.
However, he says that “killer
applications” for AO have yet to
be developed. “But, if there is a
disease that can be detected early
using only AO technology AND
there is a cure, then it’s possible
that basic AO imaging systems
will be common.”
Photo by: Brandon Lujan, MD
R
ecent advances in ophthalmic imaging
using adaptive optics (AO) and optical
coherence tomography (OCT) have
resulted in the ability to view unprecedented
anatomical detail.
These technologies are now being applied
to clinical presentations in order to understand the anatomical changes associated with
the disorder and to diagnose and treat clinical conditions.
Tomorrow morning’s Hirsch Research
Symposium, “Clinical Application of Advanced Ocular Imaging,”
will highlight the
applications of these newer imaging techniques for genetic retinal conditions, as well
as for management of retinal diseases such as
age-related macular degeneration.
The presenters are among the foremost
authorities on adaptive optics. Their discussions will include:
Spectral-domain OCT combined with improvements in software and acquisition
techniques have refined the quantification of pathological features, such as drusen
volume and geographic atrophy area (shown here).
AO for Cones and Color Vision
Jay Neitz, PhD, a color vision researcher
and Professor of Ophthalmology at University of Washington School of Medicine, will
present “Retinal Imaging as a Window into
Causes and Possible Treatment of Clinical
Disorders of Cones and Color Vision.”
“Mutations in the genes encoding the cone
photopigments are associated with a spectrum of vision disorders, ranging from simple
color vision defects to disorders associated
with severe vision loss,” Dr. Neitz says. “The
different mutations have very different effects
on cone structure, function and viability.
This has been revealed by new imaging technologies: OCT and AO imaging.”
What is ‘Adaptive Optics’? And How Does it Involve Eye Care?
Adaptive optics (AO) is not an imaging modality, but rather a technology that can be used in combination with imaging modalities to improve their performance. AO was originally developed for ground-based telescopes to remove atmospheric blur.
Since the 1990s, it’s also been used for retinal imaging.
Specifically, AO refers to systems that adapt to compensate for optical effects introduced by the medium between the
object and its image (i.e., wavefront distortions). For instance, AO is used in telescopes and laser communication systems to
remove the effects of distortions from the earth’s atmosphere. In retinal imaging systems, AO is used to reduce optical aberrations created by ocular structures, such as from the lens, pupil and cornea.
Adaptive optics works by measuring the distortions in a wavefront and compensating for them with a device (such as a
deformable mirror or a liquid crystal array) that corrects those errors.
AO has become a valuable tool in vision research for studying structure and function of the microscopic retina, as well as
the onset and progression of disease.
12
AAO TIMES NOVEMBER 14, 2014
Consequently, these new imaging technologies are providing information about which
disorders are likely to be amenable to novel
treatments, such as gene therapy, Dr. Neitz
says.
AO and OCT for AMD
Brandon Lujan, MD, Medical Retina and
Imaging Specialist at West Coast Retinal
Medical Group and at UC Berkeley, will
cover “Spectral Domain OCT Imaging of
Age-related Macular Degeneration.”
“I will discuss the many uses of spectral
domain OCT (SD-OCT) imaging in AMD
management and clinical studies, as well as
future frontiers of SD-OCT used to improve
the understanding of the pathogenesis of
AMD,” Dr. Lujan says. “The speed and resolution of SD-OCT, combined with software
development and improvements in acquisition techniques, have achieved refinements in
the diagnosis of disease and quantification of
pathological features, such as drusen volume
and geographic atrophy area.”
These advanced metrics are currently guiding clinical decision-making and will become
increasingly important as key endpoints in
clinical trials for novel therapeutic agents,
Dr. Lujan says.
ACADEMY 2014 DENVER
REVIEW OF OPTOMETRY
WWW.REVIEWOFOPTOMETRY.COM
Science Shines in the Spotlight
I
n a unique pairing, clinician scientists and company representatives came together at the Academy’s annual press conference on Wednesday
to present updates from their respective worlds.
Here’s a look at some of the key findings from the
scientific program:
• A study showed that smokers exhibit
increased hexanoyl-lysine (HEL) levels, a
byproduct of an alteration in fatty acids
that increases tear evaporation. Smokers
also have higher tear thinning rates compared to
nonsmokers, according to Ezell and BSK Research
Fellow Daniel Powell, OD, PhD, FAAO, of the
Ocular Surface Institute in Houston.
Source: “Tear Lipid Peroxidation and Tear Film Measurements in Young
Nonsmokers and Cigarette Smokers”
Source: “Hands-free Phone Communication Decreases Throughput on Color
and Luminance Tasks”
• A new imaging modality called
optical coherence elastography (OCE)
successfully measures corneal stiffness after collagen crosslinking, using
a micro air pulse to digitally palpate the cornea,
then recording the spatial variations that result,
according to Michael D. Twa, OD, PhD, FAAO,
Associate Dean of the University of Alabama at
Birmingham School of Optometry. “It’s noninvasive and sensitive to meaningful changes in tissue
surface,” Dr. Twa said.
Source: “Optical Coherence Elastography Imaging of the Cornea”
• Human corneal epithelial cells
(HCECs) treated with vitamin D
increased genes associated with immunity and lowered pro-inflammatory
cytokines, reported Ezell Fellow Rose Y. Reins,
PhD, Graduate Research Assistant at the University of Texas Health Science Center at Houston.
The results showed vitamin D’s protective role for
HCECs.
• To better understand how patients perceive contact lens discomfort,
researchers tested different protocols for
measuring patient response to mechanical stimuli. The study will enable future efforts to
understand psychological factors at work in sensations of lens awareness and subjective ratings of
comfort, according to Ezell Fellow William Ngo,
OD, BSc, FAAO, of Waterloo, Ontario’s Centre
for Contact Lens Research.
Source: “Vitamin D Decreases IL-8 Expression After Induction of Inflammation
and Influences Gene Expression in Human Corneal Epithelial Cells”
Source: “Comparison of Two Sensory Panel Selection Strategies for Beginning
and End of Day Lens Discomfort”
• Stereopsis training that presents
different stimuli to each eye improves
stereoacuity thresholds and visual acuity
in patients with amblyopia, Ezell Fellow
Cristina Law, OD, FAAO, said. In the
study, the patients viewed two rectangles through
a four-mirror stereoscope with binocular disparity
between the right and left eye and patients chose
which rectangle looked closer. Neural plasticity
allows some ambylopes to regain lost vision.
• Patients with prior traumatic brain
injury experienced worse photopotentiation than healthy control patients, according to Patrick D. Shorter, OD, a graduate
student at the Ohio State University in Columbus.
Source: “Dichoptic Varied-Contrast Stereopsis Training Improves Disparity
Thresholds and Visual Acuity in Adult Amblyopes”
• After 22 children with amblyopia
underwent treatment with a headset that
alternately occludes each eye at a rapid
frequency, 92% showed improvement
in visual acuity and stereopsis, according to Bruce
Moore, OD, FAAO, Marcus Professor of Pediatric
Studies at New England College of Optometry in
Boston. The device improved upon conventional
patching.
Source: “Eyetronix Flicker Glass (EFG Treatment of Refractive Amblyopia)”
• Hands-free cell phones do not reduce
distracted driving, particularly during
low-contrast visual tasks. Computer
simulations show that sensitivity and
response time are both impaired, according to
Jeff Rabin, OD, MS, PhD, FAAO, of San
14
Antonio’s University of the Incarnate Word
Rosenberg School of Optometry.
AAO TIMES NOVEMBER 14, 2014
Source: “Altered Adaptation of the Pupillary Light Reflex in Photophobic Individuals with Traumatic Brain Injury”
• When patients with primary openangle glaucoma had beta-zone peripapillary atrophy (ß-PPA), juxtapapillary
choroidal volumetric (JCV) measures
were reduced compared to normal healthy eyes,
suggesting a relationship between glaucoma,
ß-PPA and JCV, said Michael Sullivan-Mee, OD,
FAAO, of the Albuquerque VA Medical Center.
Source: “Relationship Between Juxtapapillary Choroidal Volume and ß-Zone
Peripapillary Atrophy in Normal and Glaucomatous Eyes”
• Lisa Young, OD, FAAO, of Chicago Glaucoma Consultants reported
that optic disc size played a role in the
accuracy of 261 exhibit hall attendees’
identification of glaucomatous optic neuropathy.
The eye doctors showed the most variance when
tasked with pinpointing glaucomatous optic neuropathy in small, glaucomatous nerves and large,
typical nerves.
Source: “Influence of Optic Disc Size and Neuro-retinal Rim Configuration on
Accurate Identification of Glaucomatous Optic Neuropathy”
Industry Innovations
• Wenzel Peikert from Oculus presented unique dry
eye assessment features of the Keratograph 5M corneal topographer, including the ability to noninvasively
assess the tear film under white or infrared illumination,
a high-res color camera, a video function to record the
tear film at 32 FPS and meibomian gland imaging capabilities.
• The BlephEx disposable micro-sponge exfoliates
lid margin debris associated with blepharitis, and
removes the food source that allows for Demodex mite
proliferation, said Rysurg CEO James Rynerson, MD.
He advised eye doctors to clean patients’ lids two to
four times per year using a six- to eight-minute office procedure.
• Volk Optical discussed two new diagnostic devices, the Volk Eye Check and the Pictor Plus handheld
imager. The Eye Check measures 17 ocular characteristics to improve screening, diagnosis and corrective
lens fitting, according to Pete Mastores. The Pictor Plus
offers high-res imaging of the retina and anterior segment, a 45°
view, a slit lamp adapter and WiFi connectivity. The portable device
weighs only 1lb.
• Extended depth of focus contact lenses for presbyopes will begin trials in 2015, said Brien Holden,
PhD, DSc, FAAO, who noted they could reduce problems of ghosting common to conventional multifocals.
Also under development by Brien Holden Vision: new
retinal imaging technology and a neuro-ophthalmic device to analyze
eye movement and pupil reactions in patients with traumatic brain
injury, both slated for release in 2015 or 2016.
• Hai Laboratories recognized that a shortcoming
of most slit lamps is their inability to allow comfortable
examination for patients with larger body types. The
company’s new Hai Elevate Slit Lamp is a compact
device with a platform that can be raised so patients
can reach the chin rest easily in all patients, said Vice President of
Marketing Jackie Hai.
• Menicon introduced a thin, flat contact lens
blister pack the size of a band-aid that, when opened,
presents the contact lens convex side up, reducing
patient confusion and error in lens insertion, said Vice
President of Marketing and Sales Scott Orphanos. A
disc in the packaging holds the contact lens in place with capillary attraction so it won’t fall out when opened. The pack contains
enough saline to keep the lens hydrated but avoids waste and difficulty in lens handling.
• The Sjö diagnostic test—a panel of seven biomarkers of Sjögren’s syndrome—offers greater sensitivity and specificity than other tests, said Mile Brujic,
OD, FAAO, speaking on behalf of Nicox. Use of Sjö
allows for earlier detection of Sjögren’s. The test, suitable for use in-office, contains blood and specimen collection kits
that can be sent to a lab with results available in a few weeks.
• Louise Culham, OD, of Sensor Medical Technology
made the case for single-use diagnostic contact lenses
in presenting its new 4-Mirror lens, a recent addition
to its portfolio of disposable lenses. Benefits include
reduced risk of infection, no need for cleaning and no
degradation of optics over time, as found in reusable lenses. She
also mentioned the company’s line of reusable binocular indirect
ophthalmoscopy lenses that come in 20D, 28D, 60D, 78D or 90D.
• Konan Medical launched the Evoke Dx, a new
visual evoked potential device. The compact unit presents checkered stimuli to test the visual pathway. A
significant advance is the use of an OLED (organic lightemitting diode) screen that’s better than LCD or LED
displays because it doesn’t introduce a luminance artifact defect,
according to Ian MacMillan, Vice President of Marketing.
• Murray Fingeret, OD, FAAO, described a new software package for the Heidelberg Spectralis OCT called
the Glaucoma Module Premium Edition that creates an
anatomic map of the eye to pinpoint the optic nerve
head and fovea, allowing for better anatomic registration that enables serial analysis. Subsequent scans are mapped to
the same location to better ascertain change over time.